They reported no expression of NLRP3 in the VAT or hypothalamus of the control group and the acetate treated PCOS groups, while there was a moderate NLRP3 expression in the VAT and marked expression in hypothalami of PCOS rats. Here, NLRP3 is linked to polycystic ovary syndrome.